Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
Shehab Mohamed, Hematologist at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
“Here we go!
We are pleased to share our newly published review exploring the emerging association between JAK2 mutations and thoracic aortic aneurysms in patients with myeloproliferative neoplasms and clonal hematopoiesis.
Title: Association between JAK2 Mutations and Thoracic Aortic Aneurysms in Myeloproliferative Neoplasms
This review summarizes current clinical and mechanistic evidence linking JAK2 V617F mutations with thoracic aortic aneurysm formation, highlighting the evolving role of clonal hematopoiesis beyond hematologic malignancy and thrombosis.
Across multiple cohorts involving more than 446,000 participants, JAK2 positivity was consistently associated with increased thoracic – but not abdominal – aortic aneurysm risk.
We also discuss the potential biologic mechanisms underlying this association, including inflammatory cytokine signaling, macrophage activation, endothelial dysfunction, extracellular matrix degradation, and vascular remodeling driven by JAK-STAT pathway activation.
Importantly, this work emphasizes the growing intersection between hematology, cardiovascular disease, inflammation, and precision medicine, while highlighting the need for prospective studies to determine the clinical implications of vascular surveillance in JAK2-mutated patients.
This publication reflects our continued interest in myeloid neoplasms, clonal hematopoiesis, thrombosis, and translational hematology research.
We look forward to continuing and expanding this work together with my core team:
Dr. Abdulrahman Al-Mashdali and Dr. Mohammed Elmourtada Abdulgayoom.
Special thanks to all collaborators, cardiology colleagues Mohammad AlTermanini, and Yahia Z Imam everyone contributing to multidisciplinary hematology research and patient care.”
Title: Association between JAK2 mutations and thoracic aortic aneurysms in myeloproliferative neoplasms
Authors: Mohamad Wajeh Dulli, Ashraf Ahmed, Mohammad Altermanini, Rasha Kaddoura, Abdulrahman F. Al-Mashdali, Mohammed Abdulgayoom, Yahia Imam, Shehab F. Mohamed

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series